Access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Access to anti-retroviral drugs, male was 22.9% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) recorded 22.9% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 9.1% on the previous year and up 165.4% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) peaked at 22.9% in 2024 and was at its lowest, 1.2%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), year by year
| Year | % | Change |
|---|---|---|
| 2000 | 1.2% | — |
| 2001 | 1.5% | +28.2% |
| 2002 | 1.8% | +18.4% |
| 2003 | 3.5% | +94.6% |
| 2004 | 3.5% | -2.7% |
| 2005 | 3.2% | -6.2% |
| 2006 | 3.7% | +14.9% |
| 2007 | 4.2% | +13.9% |
| 2008 | 4.6% | +7.7% |
| 2009 | 5.3% | +16.5% |
| 2010 | 5.9% | +11.6% |
| 2011 | 6.2% | +5.1% |
| 2012 | 6.8% | +9.2% |
| 2013 | 7.4% | +8.0% |
| 2014 | 8.6% | +17.2% |
| 2015 | 10.1% | +17.2% |
| 2016 | 11.9% | +17.4% |
| 2017 | 13.3% | +12.1% |
| 2018 | 15.7% | +17.6% |
| 2019 | 17.2% | +10.1% |
| 2020 | 16.9% | -1.8% |
| 2021 | 17.1% | +0.8% |
| 2022 | 19.0% | +11.5% |
| 2023 | 21.0% | +10.2% |
| 2024 | 22.9% | +9.1% |
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2003 | +94.6% | 1.8% | 3.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.3% | 1.2% | 5.3% | 10 |
| 2010s | 10.3% | 5.9% | 17.2% | 10 |
| 2020s | 19.4% | 16.9% | 22.9% | 5 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
More gender data for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Labor force, female 43.88 million (2025)
- Labor force, female, per capita 0.0586 units per person (2025)
- Labor force, female, per unit of GDP 0 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2 % change on previous year (2025)
- Labor force, female, per square kilometre 4.23 units per square kilometre (2023)
- Ratio of female to male youth unemployment rate (% ages 15-24) 163.7% (2025)
- School life expectancy, primary to tertiary, female 12.65 years (2018)
- School life expectancy, primary to tertiary, male 13.15 years (2018)
- Proportion of women in ministerial level positions 13.2% (2025)
- Ratio of female to male youth unemployment rate (%) 182.6% (2021)
All data for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) →
Frequently asked questions
- What is access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Access to anti-retroviral drugs, male in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) was 22.9% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- The highest recorded value was 22.9% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- The lowest recorded value was 1.2% in 2000.
- How does Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Over the last ten years it is up 165.4%. The long-run trend across the full record is volatile.
- Where does this Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.